clinical trial · NCT06765226
Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps
Abiomed Inc.·—·recruiting·n = 200
Heart Failure
brief summary
Analysis of cell and protein deposits on the Impella Heart Pump.
started
Sep 21, 2025
primary completion
Jul 31, 2030
completion
Jan 31, 2031
last updated
Oct 3, 2025
detailed description
The Impella heart pump supports patients in cardiogenic shock for various reasons and has passed safety and biocompatibility evaluations. The planned investigation aims to further analyze cell and protein adhesion on these pumps and the effects of their prolonged use, especially in scenarios like bridge-to-transplant, recognizing preclinical testing limitations.
official title
Abiomed Impella Pump Return Registry - Observational Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol